Skip to content
Review Open access

Rapid Diagnostics for Distinguishing Bacterial and Viral Infections: A Review of Technologies, Clinical Utility, and Stewardship Implications

Sep 2026 · Biosensors · Vol 16, pp. 499 · 0 citations · 111 references
Medicine

TL;DR

Current and emerging rapid diagnostic technologies for differentiating bacterial and viral infections, including molecular assays, rapid antigen tests, biomarker-based diagnostics, host-response platforms, hematologic methods, and artificial intelligence-based decision-support systems are examined.

Abstract

Antimicrobial resistance (AMR) is a growing global health threat driven in part by inappropriate and unnecessary antibiotic use resulting from diagnostic uncertainty at the point of care. In outpatient and acute-care settings, clinicians are often unable to rapidly distinguish between viral and bacterial infections, leading to empiric antibiotic prescribing that contributes to the emergence and spread of resistant pathogens. This review examines current and emerging rapid diagnostic technologies for differentiating bacterial and viral infections, including molecular assays, rapid antigen tests, biomarker-based diagnostics, host-response platforms, hematologic methods, and artificial intelligence-based decision-support systems. These technologies are evaluated based on diagnostic accuracy, turnaround time, cost, accessibility, and clinical actionability within real-world healthcare settings. Although several emerging and point-of-care (POC) technologies can provide results within approximately 6–15 min, their ability to consistently align with the timing, workflow, and clinical decision-making requirements of frontline outpatient and emergency-care settings remains variable and incompletely established. Future progress in antimicrobial stewardship will depend on developing rapid, clinically actionable diagnostic systems that integrate seamlessly into patient care and reduce unnecessary antibiotic use.

Read PDF

Similar papers

Oct 2026

A-108 Comprehensive Performance Evaluation of a Rapid, Universal, Sepsis Diagnostic Workflow that identifies Pathogens and characterizes their Antimicrobial Resistance

ASPIRE workflow is a novel, cutting-edge, rapid, and universal Sepsis diagnostic workflow that can identify pathogens and characterize their AMR, directly from whole blood within a clinically actionable TAT, within 6 to 8 hours using nanopore sequencing.

Ramya Vm, T. Hall, D. Sharma et al. · 0 citations
Review Open access Oct 2026

Point-of-care testing in the diagnosis of infectious diseases

Point-of-care testing (POCT) has emerged as an indispensable diagnostic strategy for addressing the increasing global burden of infectious diseases and the worsening threat of antimicrobial resistance. Owing to prominent advantages such as rapid detection of infectious agents, portability, and ease of accessibility, PO...

Quan Fang, Yu-Yan Lin, Gui-Xue Hu et al. · 0 citations
Review Open access Oct 2026

Syndromic Testing in Clinical Microbiology and Infectious Diseases: An Updated Review of Diagnostic Performance, Clinical and Healthcare Impact, and Emerging Developments

Syndromic testing, defined as the simultaneous nucleic acid amplification-based detection of multiple potential pathogens and antimicrobial resistance (AMR) determinants directly from clinical specimens, has transformed laboratory diagnosis of infectious diseases in the United States over the past two decades. In contr...

Gui-Qing Wang, Fei Chen · 0 citations
Open access Oct 2026

Sensitivity and specificity of a rapid, point-of-care assay distinguishing bacterial from viral infections in acute care settings

ABSTRACT Differentiating between bacterial and viral infections is essential in the emergency department (ED) to guide appropriate antibiotic treatment. Recent assays, such as the Food and Drug Administration (FDA)-cleared MeMed BV assay, can help with this distinction. The MeMed BV assay measures three host immune pro...

Maria E. Sundaram, Taylor A. Wahlig, Sophie Arbefeville · 0 citations
Review Open access Oct 2026

Emerging technologies for antimicrobial resistance detection in clinical microbiology

Objective: to critically evaluate emerging technologies for antimicrobial resistance (AMR) detection in clinical microbiology, highlighting their applications, advantages, and limitations. Methodology: a systematic literature review was conducted following PRISMA guidelines. Searches were performed in the PubMed/MEDLIN...

Thaynara Da Silva Brilhante, Raquel Gadelha Rafael, Vittoria Gabriele Vasconcelos Martins et al. · 0 citations
Review Oct 2026

Beyond the panel: molecular detection is not diagnosis.

It is argued that the decision to start, continue or stop antibiotics must remain basically clinical; that the detection of nucleic acids is not equivalent to the diagnosis of an infection; and that sample quality, colonization, contamination, off-panel pathogens and prior antibiotic exposure may mitigate the interpret...

V. Fihman, H. Jacquier, K. Razazi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.